Skip to main content
Help us improve emc by letting us know which of the following best describes you
Patient or Carer
Healthcare Professional
Other Professional
Toggle navigation
Home
Medicines
COVID-19 VACCINES
Browse Medicine A-Z
Browse Active Ingredient A-Z
Medicines with Black Triangle
Discontinued Medicines
Report Side Effect
RMM Directory
Companies
Latest Updates
About emc
Help
Sign up
|
Log in
Search emc: Enter medicine name or company
Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
GO
Advanced Search >
Search results for
"trastuzumab"
16 results found
Save this search
Page 1 of 1
Filter Search Results
Sort by
Product Name A to Z
Product Name Z to A
Company Name A to Z
Company Name Z to A
Updated - Newest First
Updated - Oldest First
Medicine Information for...
Healthcare Professionals (SmPC)
Patients (PIL)
Includes material to help reduce the risk associated with using this medicine (RMM)
This medicine is subject to additional monitoring
Includes patient information for visually impaired
Legal Categories
POM - Prescription only Medicine
Active Ingredients
pertuzumab
trastuzumab
trastuzumab deruxtecan
trastuzumab emtansine
Companies
Accord Healthcare Limited
Amgen Ltd
Daiichi Sankyo UK Limited
Napp Pharmaceuticals Limited
Organon Pharma (UK) Limited
Pfizer Limited
Roche Products Limited
Back to top
Enhertu 100 mg powder for concentrate for solution for infusion
trastuzumab deruxtecan
Daiichi Sankyo UK Limited
SmPC
Patient Leaflet
Risk Materials
Herceptin 150mg Powder for concentrate for solution for infusion
trastuzumab
Roche Products Limited
SmPC
Patient Leaflet
Herceptin 600 mg Solution for Injection in Vial
trastuzumab
Roche Products Limited
SmPC
Patient Leaflet
Herzuma 150 mg powder for concentrate for solution for infusion
trastuzumab
Napp Pharmaceuticals Limited
SmPC
Patient Leaflet
Herzuma 420 mg powder for concentrate for solution for infusion
trastuzumab
Napp Pharmaceuticals Limited
SmPC
Patient Leaflet
Kadcyla 100 mg Powder for Concentrate for Solution for Infusion
trastuzumab emtansine
Roche Products Limited
SmPC
Patient Leaflet
Risk Materials
Kadcyla 160 mg Powder for Concentrate for Solution for Infusion
trastuzumab emtansine
Roche Products Limited
SmPC
Patient Leaflet
Risk Materials
Kanjinti 150 mg powder for concentrate for solution for infusion
trastuzumab
Amgen Ltd
SmPC
Patient Leaflet
Kanjinti 420 mg powder for concentrate for solution for infusion
trastuzumab
Amgen Ltd
SmPC
Patient Leaflet
Ontruzant 150 mg powder for concentrate for solution for infusion
trastuzumab
Organon Pharma (UK) Limited
SmPC
Patient Leaflet
Ontruzant 150 mg powder for concentrate for solution for infusion (Northern Ireland)
trastuzumab
Organon Pharma (UK) Limited
SmPC
Patient Leaflet
Phesgo 1200 mg/600 mg solution for injection
pertuzumab, trastuzumab
Roche Products Limited
SmPC
Patient Leaflet
Phesgo 600 mg/600 mg solution for injection
pertuzumab, trastuzumab
Roche Products Limited
SmPC
Patient Leaflet
Trazimera 150 mg powder for concentrate for solution for infusion
trastuzumab
Pfizer Limited
SmPC
Patient Leaflet
Trazimera 420 mg powder for concentrate for solution for infusion
trastuzumab
Pfizer Limited
SmPC
Patient Leaflet
Zercepac 150 mg powder for concentrate for solution for infusion
trastuzumab
Accord Healthcare Limited
SmPC
Patient Leaflet
Page 1 of 1
×
Save this search
Search name
Name this search
Please provide a name for this search
Enter a description
Name this search
;
Skip to main content
